GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ScandiDos AB (OSTO:SDOS) » Definitions » ROE % Adjusted to Book Value

ScandiDos AB (OSTO:SDOS) ROE % Adjusted to Book Value : -2.71% (As of Jul. 2024)


View and export this data going back to 2014. Start your Free Trial

What is ScandiDos AB ROE % Adjusted to Book Value?

ScandiDos AB's ROE % for the quarter that ended in Jul. 2024 was -5.81%. ScandiDos AB's PB Ratio for the quarter that ended in Jul. 2024 was 2.14. ScandiDos AB's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2024 was -2.71%.


ScandiDos AB ROE % Adjusted to Book Value Historical Data

The historical data trend for ScandiDos AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ScandiDos AB ROE % Adjusted to Book Value Chart

ScandiDos AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.46 -0.77 -7.24 -9.76 -19.26

ScandiDos AB Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.76 -5.26 -0.95 -43.64 -2.71

Competitive Comparison of ScandiDos AB's ROE % Adjusted to Book Value

For the Medical Devices subindustry, ScandiDos AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ScandiDos AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ScandiDos AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ScandiDos AB's ROE % Adjusted to Book Value falls into.



ScandiDos AB ROE % Adjusted to Book Value Calculation

ScandiDos AB's ROE % Adjusted to Book Value for the fiscal year that ended in Apr. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-34.09% / 1.77
=-19.26%

ScandiDos AB's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-5.81% / 2.14
=-2.71%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ScandiDos AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of ScandiDos AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


ScandiDos AB Business Description

Traded in Other Exchanges
N/A
Address
Uppsala Science Park, Uppsala, SWE, S-751 83
ScandiDos AB is a Sweden based company involved in providing Radiation Therapy. It provides measurement systems and software that are designed for QA and validation of treatments that are being implemented in clinics around the world.

ScandiDos AB Headlines

No Headlines